Pfizer 1Q Revenues: $14.6 billion (+45%) 1Q Earnings: $4.9 billion (+45%) Comments: Vaccines sales were $4.9 billion in the quarter, up from $1.6 billion in 1Q20 driven by BNT162b2, which contributed $3.5 billion in global revenues. Excluding BNT162b2, revenues grew 8%. Eliquis revenue was up 25% operationally to $1.6 billion. Oncology sales were up 18% to $2.9 billion. Internal Medicine sales were up 11% to $2.6 billion. Hospital sales were up 12% to $2.3 billion. Inflammation & Immunolo...